We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Molecular Processes of the Relaxation Response in Older Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00179569
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : November 5, 2007
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to examine the molecular (nitric oxide) and biochemical (epinephrine, norepinephrine, cortisol and ACTH) parameters that are associated with RR elicitation and which may counteract the effects of acute stress in the elderly.

Condition or disease Intervention/treatment Phase
Stress Behavioral: Relaxation response Phase 2

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Molecular Processes of the Relaxation Response in Older Adults
Study Start Date : August 2005
Study Completion Date : September 2007
Arms and Interventions

Intervention Details:
    Behavioral: Relaxation response
    8 weeks of relaxation response training

Outcome Measures

Primary Outcome Measures :
  1. A primary goal of this study is to quantify the magnitude of relaxation response elicitation by comparing oxygen consumption during rest versus during elicitation of the relaxation response in a sample of healthy older adults. [ Time Frame: 8 weeks ]

Secondary Outcome Measures :
  1. A second area of interest is the relationship between exhaled levels of nitric oxide (NO) and oxygen consumption (VO2) during relaxation response elicitation. [ Time Frame: 8 weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   60 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • 60-80 years of age
  • healthy individuals
  • willing and able to attend treatment sessions
  • willing to learn how to do and practice the relaxation-response
  • access to a working telephone
  • read and write English

Exclusion Criteria:

  • Major medical or psychiatric illness
  • asthma or seasonal allergies (resulting in nitric oxide levels >60 ppb)
  • smoking
  • previous relaxation-response practice
  • current use of the following medications:systemic corticosteroids, anti-convulsants/psychotics, immunosuppressants, cytotoxic therapy, anabolic steroids, antidepressants (other than SSRIs), dicyclomine, bile acid binding resins, or sympathomimetic medication
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00179569

United States, Massachusetts
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Centers for Disease Control and Prevention
Principal Investigator: Jeffery A Dusek, PhD Beth Israel Deaconess Medical Center
More Information

ClinicalTrials.gov Identifier: NCT00179569     History of Changes
Other Study ID Numbers: 2004P-000418
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: November 5, 2007
Last Verified: November 2007